Ramin Najafi, Chief Executive Officer at NovaBay Pharmaceuticals, Inc. (NBY), bought 500 shares at $1.59 ($795) on 2011-05-27, disclosed to the SEC on 2011-05-31.
Open-market purchase of $795 NBY by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| NBY | BUY | 2014-12-15 | $33K | — | Filing → |
| NBY | BUY | 2014-12-11 | $12K | — | Filing → |
| NBY | BUY | 2014-12-08 | $16K | — | Filing → |